Navigation Links
Cardica and Intuitive Surgical to Host Educational Symposium on 'Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair'
Date:1/18/2008


- Event to be Held January 27th at 7:00 p.m. Eastern Time in Conjunction with

Leading Cardiothoracic Surgeons Conference - REDWOOD CITY, Calif. and SUNNYVALE, Calif., Jan. 18 /PRNewswire-FirstCall/ -- Cardica, Inc. (Nasdaq: CRDC) and Intuitive Surgical, Inc. (Nasdaq: ISRG) today announced they will host an evening symposium on the topic of "Advanced Techniques and Technologies in Robotic Coronary Revascularization and Mitral Valve Repair." The symposium will feature Intuitive's da Vinci(R) Surgical System and Cardica's innovative C-Port (R) Distal Anastomosis Systems, which are designed to allow surgeons to automate the attachment of blood vessel grafts during coronary artery bypass graft (CABG) procedures, replacing traditional hand-sewn sutures.

The educational event will take place on Sunday, January 27, from 7 to 9 p.m. Eastern Time at the Renaissance Hotel Grand Ballroom in Fort Lauderdale, Fla. during the 44th Annual Meeting of The Society of Thoracic Surgeons (STS), the largest meeting of cardiothoracic surgeons in North America. This activity is not part of the official scientific program of STS.

"This symposium offers cardiothoracic surgeons an opportunity to learn from their peers who are leading the adoption of beating heart robotic CABG surgery and the establishment of robotic mitral valve surgery as standard of care," said Louis A. Brunsting, III, M.D., cardiothoracic surgeon for Centennial Medical Center in Nashville, Tennessee. "The Cardica C-Port systems and da Vin
'/>"/>

SOURCE Cardica, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related biology technology :

1. Cardica and Cook Sign Agreement to Expand Cook Vascular Closure Device Product Family
2. Cardica Receives European CE Mark for C-Port Flex A System for Use in Coronary Artery Bypass Surgery
3. Cardicas C-Port(R) Flex A Anastomosis System Allows Surgeons to Perform Revolutionary Closed-Chest Heart Bypass Surgeries
4. Surgical and Trauma Wound Care Market to Tie Up $7 Billion in Sales by 2011
5. National Surgical Hospitals Acquires Majority Share of Houston-Area Surgery Center
6. MAKO Surgical Corp. Files Registration Statement for Initial Public Offering of Common Stock
7. CryoLife Signs Distribution Agreement for Inclusion of BioGlue(R) Surgical Adhesive in Hernia Repair Kit with Proxy Biomedical Surgical Meshes
8. New Orthopedic Surgical Robotics Company Opens Its Doors; Files with the FDA for Clearance of Its Flagship Product
9. Survey of More than 600 Patients Treated with Tracleer(R) (bosentan) Reveals Actelion Sure Steps(R) Patient Support Program Provides Valuable Educational Information
10. Magnifi Group Demonstrates Industrys First Interactive Educational Program (IEP) for Spine Fellows
11. Melanoma Research Foundation and Seattle Cancer Care Alliance Host Educational Symposium and Reception for Melanoma Patients, Family Members and Healthcare Providers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/2/2008)...y Technology Receive Funding, From Allied Minds to... of Aliquots, BOST...d investment,corporation specializing in early sta...y,s Office of Technology Development, and Northeas...t Instruments, LLC, a new,spin-out focused on the ...
(Date:7/2/2008)...-- Pearl Therapeutics, Inc.,a biopharmaceutical c...iseases, today announced that it has completed the...s financing was executed as an extension to,its fi...articipating in the,internal round were Pearl,s ex...s, 5AM Ventures and Nektar Therapeutics. In total,...
(Date:7/2/2008)...-- Research conducted at The,Walter and Eliza Hall... a,major licensing agreement signed between Austra...nd Germany-based pharmaceutical company, Merck,Ser...nt, Merck Serono will seek,to develop new treatmen...e,conditions. These prospective treatments will be...
(Date:7/2/2008).../ -- WuXi PharmaTech (NYSE:,WX), a leading pharmac...,and development outsourcing company with operatio... that it has appointed Mr. Bob Zhu as Vice Preside...m.com/cgi-bin/prnh/20040705/CNM002LOGO ), Prior ... of Asia Human,Resources with Electronic Arts (EA)...
Breaking Biology Technology:Investment Firm Allied Minds to Commercialize New Frozen Aliquotter Technology with Two Local Major Universities. 2Pearl Therapeutics Closes $18 Million Financing Round Led By Committed Investors 2MS Drug Development Agreement Based on WEHI's Medicinal Chemistry 2WuXi PharmaTech (NYSE: WX) Appoints Mr. Bob Zhu as VP of HR 2
...echnology , a unit of Fisher Biosciences, has cont... to distribute GenTel,s trademarked PATH brand thi...use of GenTel technology in developing new protein...ry. GenTel slides are specifically designed for pr...of disease biomarkers to improve the safety and ef...
...th the recently developed APR reactor UW-Madison ...s. In 2002, UW stem cell pioneer James Thomson w...ge and Sergey Brin. This year, it might be James D... two men will be honored as New Fellows of the New...s itself a "global meeting ground, a virtual think...
...nst CoreComm Voyager, Inc . for violating Wiscons... by the state attorney general. , ,CoreComm, a Del...s and related services to Wisconsin customers, man...nsin-based internet provider subsequently acquired...y Circuit Court, alleged that CoreComm failed to c...
...ebsite for the new century, complete with RSS news...s of everything important to the average person, s...ses and changes in the status of known sex offende...ted shades of gray, blue and tan. It contains link...et a free credit report, and gives up-to-the minut...
Other Biology Technology:Wisconsin scientists to be recognized for innovative biofuel technology 2Wisconsin scientists to be recognized for innovative biofuel technology 3CoreComm slapped by AG for violating telecommunications laws 2State web site needs overhaul 2State web site needs overhaul 3State web site needs overhaul 4
(Date:7/3/2008)...hers at the David Geffen School of Medicine at UCL... known as sodium glucose co-transporters (SGLTs), ...teins are used in the treatment of chronic diarrhe...f millions of children each year. The solution of ...new drugs designed to treat patients with diabetes...
(Date:7/3/2008)...bservation satellites have provided vital informat...icularly long crisis response window following the...n 2 and 3 May 2008. , Immediately after the disa...tarian Affairs (OCHA) asked the International Char... ,the Charter, for support by providing immediate...
(Date:7/3/2008)...IS Want to slow the signs of aging and live longe...tting back on calories could be a promising strate...o slow the aging process in rats and mice. While s...cts the aging process in rodents, one popular hypo...oid hormone, triiodothyronine (T3), which then slo...
(Date:7/2/2008)...GSTON, R.I. July 2, 2008 Standing in a greenhous... was smiling even though it appeared that somethin...pecies of grass she planted last February in hundr...ofessor of turf science wasn,t surprised. That,s ...saltier water for five months, and few varieties o...
Breaking Biology News(10 mins):UCLA researchers clarify function of glucose transport molecule 2Extended cyclone relief efforts aided from space 2Extended cyclone relief efforts aided from space 3Looking for the Founatain of Youth? Cut your calories, research suggests 2Search for salt tolerant grasses aims to improve roadside plantings 2Cryo Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics Inc 2813 1Cryo Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics Inc 2813 2Cryo Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics Inc 2813 3Cryo Cell Announces Research Collaboration Agreement with Saneron CCEL Therapeutics Inc 2813 4Access Pharmaceuticals Announces 242 7 Million New Equity 2811 1Access Pharmaceuticals Announces 242 7 Million New Equity 2811 2Access Pharmaceuticals Announces 242 7 Million New Equity 2811 3Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer 1282 1Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer 1282 2Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer 1282 3Peregrine Pharmaceuticals Opens Enrollment in Phase II Clinical Trial of Bavituximab in Patients with Advanced Breast Cancer 1282 4Merial to Screen Chimerix Chemical Library for Animal Health Drug Leads 2809 1Merial to Screen Chimerix Chemical Library for Animal Health Drug Leads 2809 2
...diers guarding a castle gate, multiple genetic def...wdery mildew disease, according to a new study. Po...s that attacks more than 9,000 species, including ...ural plants such as roses and cucumbers. The resea...in of the Carnegie Institution,s Department of Pla...
...reatment for stroke has taken a major step forward...al trial. , Researchers at The University of Manch...rally occurring protein called IL-1ra protects bra...y Professor Nancy Rothwell and Dr Pippa Tyrrell, h...ial of IL-1ra in patients, which are published in ...
...t accompanied the recent drought was the underlyin...ughout the Southwest, according to new research. ,...osystem for decades. Hotter temperatures coupled w...bal climate change models. The new finding suggest...global climate change. , "We documented a massive...
...e experiment has resulted in one of the longest re...ened a new door for anti-aging research in humans.... extra copy of the SIR2 gene can promote longevity...was covered widely and incorporated into anti-agin...gy companies. , Now, molecular geneticists at the...
Other Biology News:Genetic defenders protect crops from fungal disease 2Genetic defenders protect crops from fungal disease 3Stroke treatment a step closer after trial 2Underlying cause of massive pinyon pine die-off revealed 2Underlying cause of massive pinyon pine die-off revealed 3Underlying cause of massive pinyon pine die-off revealed 4New technique multiplies life span in simple organisms 2New technique multiplies life span in simple organisms 3
Rabbit polyclonal to TAB1 ( Abpromise for all tested applications). entrezGeneID: 10454 SwissProtID: Q15750
Rabbit polyclonal to NIRF ( Abpromise for all tested applications). Antigen: Synthetic peptide derived from residues 186-235 of human NIRF. Entrez Gene ID: 115426 Swiss Protein ID: Q96PU
Rabbit polyclonal to DcR2 ( Abpromise for all tested applications). entrezGeneID: 8793 SwissProtID: Q9UBN6
Fau I from New England Biolabs
Biology Products: